UNC Pharmacy Grand Rounds

The UNC Eshelman School of Pharmacy and the American Society of
Health-System Pharmacists, in partnership, present UNC Pharmacy Grand Rounds. This new, subscription-based service provides a series of video webcasts designed specifically to meet the continuing education needs of pharmacists in health systems.

These webcasts will provide current continuing education from practicing clinicians and pharmacy administrators through one hour, ACPE-accredited presentations given once a month. For a full list of benefits, a one-page executive summary is available.

URGENT! You must process all outstanding CE credit by June 30, 2014
This CE credit includes all ASHP activities participated in to date: meetings, workshops, webinars, recorded webinars, home study, print, etc. For future activities that you have not yet participated (meetings, workshops, webinars, recorded webinars, home study, print, etc...), you will have 60 days from the activity to process your CE. Learn More

Upcoming Sessions

All sessions begin at Noon Eastern Time.

July 8, 2014
Long Term Management of Epilepsy: Past, Present, and Future
Shauna S. Garris, PharmD, BCPP, BCPS

ACPE activity #0204-9999-14-456-L01-P
1 hour (0.1 CEU) CPE
A live webcast presented on Tuesday, July 8, 2014, from 12 p.m. – 1 p.m. ET

Learning Objectives
At the conclusion of this knowledge-based educational activity, participants should be able to

  1. Differentiate safety, efficacy, and therapeutic drug monitoring profiles between the three generations of antiepileptic agents.
  2. Recommend appropriate monitoring and treatment of anti-epileptic drug (AED)- related chronic adverse events.
  3. Identify patients appropriate for AED discontinuation.

Faculty
Shauna Garris, Pharm.D., BCPP, BCPS
Pharmacy Clinical Specialist, Psychiatry and Neurology
University of North Carolina (UNC) Healthcare
Adjunct Assistant Professor
UNC Eshelman School of Pharmacy
Chapel Hill, North Carolina

Shauna Garris, Pharm.D., BCPP, BCPS, is a pharmacy clinical specialist at the University of North Carolina (UNC) Healthcare, practicing in psychiatry and neurology. She also has a faculty appointment as Adjunct Assistant Professor in the Division of Practice Advancement and Clinical Education at the UNC Eshelman School of Pharmacy in Chapel Hill, North Carolina. Her practice serves as an active training site for pharmacy students and residents.

Dr. Garris earned a Doctor of Pharmacy degree from the UNC Eshelman School of Pharmacy. She completed PGY1 and PGY2 residencies in psychiatric pharmacy practice at the Medical University of South Carolina. Prior to coming to UNC Healthcare, she worked as a clinical science manager in neuroscience and pain global pharmaceutical research and development. She also has experience practicing at a North Carolina state psychiatric facility.

Aug 12, 2014
Overview of an Investigational Drug Service
Scott Sorensen, RPh, PhD
Sue Pope, RPh

ACPE activity #0204-9999-14-457-L04-P
1 hour (0.1 CEU) CPE
A live webcast presented on Tuesday, August 12, 2014, from 12 p.m. – 1 p.m. ET

Learning Objectives
At the conclusion of this knowledge-based educational activity, participants should be able to

  1. Explain the principles that are used to evaluate the ethics and regulate the conduct of human research protocols.
  2. Define an Investigational New Drug (IND).
  3. Identify relevant regulations that govern the practice of pharmacy in relation to handling and dispensing INDs.
  4. Identify the operational benefits of a non-integrated investigational drug service (IDS).
  5. Describe standards that may be adopted for dispensing investigational agents.

Faculty
Scott Sorensen, Ph.D.
Clinical Pharmacist
Oncology Investigational Drug Services (IDS)
UNC Lineberger Comprehensive Cancer Center
N.C. Cancer Hospital
University of North Carolina (UNC) Healthcare
Chapel Hill, North Carolina

Scott Sorensen, Ph.D., is Clinical Pharmacist at the UNC Lineberger Comprehensive Cancer Center N.C. Cancer Hospital in Chapel Hill, North Carolina. Dr. Sorensen coordinates drug therapy for oncology patients in the N.C. Cancer Hospital and provides pharmacy services for investigational drug therapy to ensure appropriateness of chemotherapy regimens and compliance with protocol standards. He also serves as a member of the Institutional Review Board in the Office of Human Research and Ethics at UNC Chapel Hill and on the pharmacy and therapeutics (P&T) committee and oncology subcommittee at UNC Healthcare.

Dr. Sorensen received his Bachelor of Science degree in pharmacy from St. Louis College of Pharmacy in St. Louis, Missouri. He also received a Doctor of Philosophy degree in pharmacology from the University of Michigan in Ann Arbor, Michigan and completed postdoctoral study in pharmacology at Emory University in Atlanta, Georgia. Prior to his current position at UNC Healthcare, he was a research scientist helping to advance pharmaceutical compounds through pre-clinical development.

Sue Pope, B.S.Pharm.
Clinical Pharmacist, Manager of Investigational Drug Service
UNC Hospitals at the University of North Carolina
Chapel Hill, North Carolina

Sue Pope, B.S.Pharm., is Pharmacy Clinical Manager in Investigational Drug Services (IDS) at the University of North Carolina (UNC) Hospitals. In this role, Ms. Pope oversees the daily operational functions of more than 300 protocols in IDS including the dispensing, billing, and accountability of these protocols across all areas of the hospital. She also manages the pharmacist and technician staff.

Ms. Pope earned her Bachelor of Science degree in pharmacy from the Medical College of Virginia at Virginia Commonwealth University in Richmond, Virginia. Ms. Pope has been the manager of IDS at UNC Hospitals for 6 years and has worked at UNC in various pharmacist roles for over 28 years.

Sept 9, 2014
Anticoagulation Treatment in Cancer Patients
Jill S. Bates, Pharm.D., M.S., BCOP

ACPE activity #0204-9999-14-458-L01-P
1 hour (0.1 CEU) CPE
A live webcast presented on Tuesday, September 9, 2014, from 12 p.m. – 1 p.m. ET

Learning Objectives
At the conclusion of this knowledge-based educational activity, participants should be able to

  1. Identify risk factors for and explain the pathogenesis of venous thromboembolism (VTE) in cancer patients.
  2. Evaluate the role of novel oral anticoagulants in patients with cancer.
  3. Select an anticoagulation agent and design an anticoagulation care plan for a cancer patient.
  4. Evaluate, monitor, and manage anticoagulation in special populations of cancer patients.

Faculty
Jill S. Bates, Pharm.D., M.S., BCOP
Attending Pharmacist, Malignant Hematology
University of North Carolina (UNC) Medical Center
Assistant Professor of Clinical Education
UNC Eshelman School of Pharmacy
Chapel Hill, North Carolina

Jill S. Bates, M.S., Pharm.D., BCOP, is a clinical pharmacy specialist in hematology/oncology within the University of North Carolina (UNC) Healthcare System and an assistant professor of clinical education at the UNC Eshelman School of Pharmacy in Chapel Hill, North Carolina. She received her Doctor of Pharmacy degree at the University of Illinois at Chicago and a research-based Master of Science degree in biochemistry and biophysics from Northern Illinois University. Dr. Bates completed ASHP-accredited pharmacy practice (PGY1) and oncology (PGY2) residencies at Duke University Medical Center. She is board certified in oncology pharmacy.

Dr. Bates holds a leadership position on the UNC Chemotherapy Policy Advisory Group and participates in the Oncology Pharmacy and Therapeutics Committee, Oncology Patient Education Committee, and the Interdisciplinary Triad Committee for performance improvement of MDE services. She is an active member of the American Society of Health-System Pharmacists (ASHP) and the Hematology/Oncology Association (HOPA). Her involvement with ASHP has included serving on the Council on Therapeutics as Vice Chair and Chair. In addition, Dr. Bates served on the New Practitioner Education Advisory Group and as a member of the Educational Steering Committee and Clinical Leadership Section Advisory Group for the Section of Clinical Specialists and Scientists. In 2012, she was elected Chair of the Section of Clinical Scientists and Specialists and currently serves in this role. Dr. Bates is a manuscript reviewer for various pharmacy journals.

Oct 14, 2014 Probiotics: Separating Fact from Fiction
Lindsay Daniels, Pharm.D., BCPS, AQ-ID
Nov 11, 2014 Antibiotic Resistance: Origins, Mechanisms and Responses
Scott Singleton, Ph.D.
Dec 9, 2014 The Affordable Care Act: What to Do When It's Really Not That Affordable?
Ginny Crisp, Pharm.D., BCACP
Jan 13, 2015 Medication Management of Chronic Gout
Emily M. Hawes, Pharm.D., BCPS, CPP
Feb 10, 2015 Acute Management of Burn Injury
Said “Moo” Sultan, Pharm.D., BCPS
Mar 10, 2015 Pharmacist Involvement in Transitions of Care
Jamie Cavanaugh, Pharm.D., CPP, BCPS
April 14, 2015 The Pharmacists Role in Curtailing the Opioid Epidemic
John M. Valgus, Pharm.D., BCOP, CPP
May 12, 2015 Worth the Hype? Updated Hypertension Guidelines Revisited
Jonathan D. Cicci, Pharm.D., BCPS
June 9, 2015 Cytomegalovirus Infection in Solid Organ Transplant: The Role of the Pharmacist
Ruth-Ann Lee, Pharm.D., CPP

For Subscribers

Log in for webcasts and archives.

Overview

As nationally recognized leaders in progressive pharmaceutical care practice, education, and research, UNC Eshelman School of Pharmacy faculty have the tools and knowledge to stay up-to-date on the most current and relevant topics in health-system pharmacy practice. A variety of topics will be presented, focusing on new information and relevant topics for health-system pharmacists. Topics are based upon educational needs, identified practice gaps, and sound adult learning principles.

In addition to the live presentation, archives of each broadcast will available for 6 months after the end of the subscription, providing home study CE credit and ensuring that enrolled learners that missed the live webcast can participate in these important CE activities.

Subscriptions are available for individuals and for hospitals. For complete information about hospital subscription levels, visit the Subscription Details page.